6.015
price up icon6.96%   0.415
 
loading

Novavax Inc Aktie (NVAX) Neueste Nachrichten

pulisher
09:40 AM

FDA Delays Final Approval of Novavax COVID Vaccine - Ashe Post & Times

09:40 AM
pulisher
05:54 AM

$175 million milestone in jeopardy as FDA delays Novavax nod - The Pharma Letter

05:54 AM
pulisher
Apr 03, 2025

‘Highly Problematic’: Acting FDA Commissioner Paused Planned OK Of Novavax Shot - insights.citeline.com

Apr 03, 2025
pulisher
Apr 03, 2025

Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Apr 03, 2025
pulisher
Apr 03, 2025

FDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofAS - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

Novavax’s Covid vaccine delayed in FDA review - The Business Journals

Apr 03, 2025
pulisher
Apr 03, 2025

Despite Headwinds, Biotech Sell-Off Could Offer Buying Opportunity: Analyst - Benzinga

Apr 03, 2025
pulisher
Apr 03, 2025

FDA delays full approval of Novavax COVID-19 vaccine even though it was on track for clearance - WBBH

Apr 03, 2025
pulisher
Apr 03, 2025

FDA Delays Full Approval Decision On Novavax's COVID-19 Vaccine (UPDATED) - Benzinga

Apr 03, 2025
pulisher
Apr 03, 2025

Novavax (NVAX) Stock Climbs Amid FDA Approval Delay for COVID-19 Vaccine - GuruFocus

Apr 03, 2025
pulisher
Apr 03, 2025

Sanofi-Novavax deal in jeopardy as FDA halts vaccine approval - Bizcommunity

Apr 03, 2025
pulisher
Apr 03, 2025

Novavax awaits FDA decision on COVID-19 vaccine BLA - Investing.com Australia

Apr 03, 2025
pulisher
Apr 02, 2025

US Drug Regulator Delays Novavax Covid Vaccine Approval - Barron's

Apr 02, 2025
pulisher
Apr 02, 2025

Novavax (NVAX) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

Apr 02, 2025
pulisher
Apr 02, 2025

FDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearance - KTVZ

Apr 02, 2025
pulisher
Apr 02, 2025

US FDA misses deadline for decision on Novavax's COVID-19 vaccine - Reuters

Apr 02, 2025
pulisher
Apr 02, 2025

Novavax Can Confirm That April 1, Was U.S FDA'S PDUFA Date For BLA Seeking Approval Of Our Covid-19 Vaccine - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Novavax set to snap six days of losses as shares trade in green - MSN

Apr 02, 2025
pulisher
Apr 02, 2025

Novavax (NVAX) COVID-19 Vaccine Approval Delayed by FDA - GuruFocus

Apr 02, 2025
pulisher
Apr 02, 2025

Novavax awaits FDA decision on COVID-19 vaccine BLA By Investing.com - Investing.com UK

Apr 02, 2025
pulisher
Apr 02, 2025

FDA Delays Full Approval Decision On Novavax's COVID-19 Vaccine - Benzinga

Apr 02, 2025
pulisher
Apr 02, 2025

Novavax (NasdaqGS:NVAX) Sees 21% Weekly Drop As Leadership Changes Shake Market - Yahoo Finance

Apr 02, 2025
pulisher
Apr 02, 2025

Exclusive | FDA Punts on Major Covid-19 Vaccine Decision After Ouster of Top OfficialWSJ - WSJ

Apr 02, 2025
pulisher
Apr 02, 2025

Novavax bid for full approval of COVID vaccine stymied by FDA - Seeking Alpha

Apr 02, 2025
pulisher
Apr 02, 2025

FDA misses deadline for decision on Novavax's COVID-19 vaccine, WSJ reports - TradingView

Apr 02, 2025
pulisher
Apr 02, 2025

FDA Misses Deadline For Covid-19 Vaccine Decision, Novavax's Application Needed More Data- WSJ - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

The Market Doesn't Like What It Sees From Novavax, Inc.'s (NASDAQ:NVAX) Revenues Yet As Shares Tumble 28% - simplywall.st

Apr 02, 2025
pulisher
Mar 31, 2025

Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out - WSJ

Mar 31, 2025
pulisher
Mar 31, 2025

Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch

Mar 31, 2025
pulisher
Mar 31, 2025

Top vaccine official’s ouster sends biotech stocks tumbling - The Boston Globe

Mar 31, 2025
pulisher
Mar 31, 2025

Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views - Fast Company

Mar 31, 2025
pulisher
Mar 31, 2025

Moderna, Novavax, Other Vaccine Makers Retreat Following Resignation of FDA's Vaccines Chief - MarketScreener

Mar 31, 2025
pulisher
Mar 31, 2025

Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says ‘wishes subservient confirmation of his misinformation and lies’ - Yahoo Finance

Mar 31, 2025
pulisher
Mar 31, 2025

Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says 'wishes subservient confirmation of his misinformation and lies' - Fortune

Mar 31, 2025
pulisher
Mar 31, 2025

Moderna, Novavax Drop After FDA’s Top Vaccine Official Exits - Bloomberg

Mar 31, 2025
pulisher
Mar 31, 2025

Biopharma, Biotech stocks tumble on FDA shakeup - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Mar 31, 2025
pulisher
Mar 31, 2025

FDA official’s ouster sends shares of vaccine makers sliding - Yahoo Finance

Mar 31, 2025
pulisher
Mar 31, 2025

Novavax seeks authorization of updated COVID shot in Europe - MSN

Mar 31, 2025
pulisher
Mar 30, 2025

Novavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy Now - Yahoo Finance

Mar 30, 2025
pulisher
Mar 28, 2025

Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch

Mar 28, 2025
pulisher
Mar 27, 2025

Why Novavax (NVAX) Dipped More Than Broader Market Today - Yahoo Finance

Mar 27, 2025
pulisher
Mar 26, 2025

Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Mar 26, 2025
pulisher
Mar 26, 2025

Moderna, Novavax Shares Are Sliding Wednesday: What's Going On?Moderna (NASDAQ:MRNA) - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Moderna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cuts - Investing.com Australia

Mar 26, 2025
pulisher
Mar 26, 2025

Where are the Opportunities in (NVAX) - Stock Traders Daily

Mar 26, 2025
pulisher
Mar 25, 2025

Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Mar 25, 2025
pulisher
Mar 25, 2025

The industry heavyweight behind Novavax’s push to bounce back - PharmaVoice

Mar 25, 2025
pulisher
Mar 24, 2025

Novavax Inc. stock rises Monday, still underperforms market - MarketWatch

Mar 24, 2025
pulisher
Mar 24, 2025

Ebola Vaccine Market Generated Opportunities, Future Scope - openPR

Mar 24, 2025
pulisher
Mar 19, 2025

Novavax (NVAX) Stock Dips While Market Gains: Key Facts - Yahoo Finance

Mar 19, 2025
$66.10
price down icon 2.65%
$73.33
price down icon 0.15%
$31.60
price up icon 0.06%
$18.91
price down icon 11.53%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 7.93%
Kapitalisierung:     |  Volumen (24h):